Lv1
50 积分 2024-02-01 加入
ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Multiple Myeloma
7个月前
已完结
Ixazomib Versus Placebo as Postinduction Maintenance Therapy in Newly Diagnosed Multiple Myeloma Patients: An Analysis by Age and Frailty Status of the TOURMALINE-MM4 Study
7个月前
已完结
The Burden of Multiple Myeloma in China: Trends from 1990 to 2021 and Forecasts for 2050
7个月前
已完结
Systematic review and model-based analysis to identify whether renal safety risks of URAT1 inhibitors are fully determined by uric acid-lowering efficacies
9个月前
已完结
Comparative efficacy and safety of uricosuric agents in the treatment of gout or hyperuricemia: a systematic review and network meta-analysis
9个月前
已完结
Multicenter Open Label Phase 3 Study of Isatuximab Plus Lenalidomide and Dexamethasone with/without Bortezomib in the Treatment of Newly Diagnosed Non-Frail Transplant Ineligible Multiple Myeloma Elderly Patients (≥ 65; < 80 Years). IFM2020-05/Benefit
1年前
已关闭
Clinical profiles and outcomes of young versus elderly patients with multiple myeloma: A retrospective observational study from a tertiary cancer center in South India
1年前
已关闭
352TiP Randomized phase III study of daratumumab (D) versus bortezomib plus D as a maintenance therapy after D-MPB for elderly or non-elderly patients refusing transplant with untreated multiple myeloma (JCOG1911, B-DASH study)
1年前
已关闭
Toxicity profile, adverse drug reactions and drug-drug interactions among geriatric cancer patients under metronomic chemotherapy in a South Indian tertiary care hospital
1年前
已完结
Risk of cancer-specific death among octogenarians with multiple myeloma: A population-based analysis
1年前
已完结
皖公网安备34019202002308
